Pharmaceutical Technology14m
AHA 2024: Plozasiran demonstrates promising Phase III results in FCS adults
During AHA 2024, data were presented from the Phase III trial of plozasiran targeting adults with genetically or clinically ...
Pharmaceutical Technology39m
AHA 2024: Lerodalciep provides promising results in open-label extension trial, LIBERATE-OLE
At AHA 2024, clinical trial results were presented from the ongoing open-label extension trial, LIBERATE-OLE, involving ...